CinCor Pharma Inc.

NASDAQ: CINC · Real-Time Price · USD
29.06
0.00 (0.00%)
At close: Feb 23, 2023, 10:00 PM

CinCor Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a
Operating Income
-82.53M -67.98M -51.8M -42.51M -22.79M -15.1M -9.93M
Interest Income
1.61M 344.51K 68.68K 21.64K 14.71K 12.77K 11.23K
Pretax Income
-88.09M -76.14M -61.45M -50.37M -26.83M -17.81M -11.43M
Net Income
-93.31M -82.62M -68.49M -54.47M -26.83M -17.81M -11.43M
Selling & General & Admin
26.59M 25.11M 22.1M 18.99M 5.53M 2.49M 1.31M
Research & Development
55.94M 42.87M 29.7M 23.52M 17.26M 12.61M 8.61M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
82.53M 67.98M 51.8M 42.51M 22.79M 15.1M 9.93M
Interest Expense
1.61M 344.51K 68.68K 21.64K 14.71K 12.77K 11.23K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
82.53M 67.98M 51.8M 42.51M 22.79M 15.1M 9.93M
Income Tax Expense
5.22M 6.48M 7.04M 4.1M n/a n/a n/a
Shares Outstanding (Basic)
40.81M 37.71M 33.43M 35.42M 35.42M 34.36M 34.36M
Shares Outstanding (Diluted)
40.81M 37.71M 33.43M 35.42M 35.42M 34.36M 34.36M
EPS (Basic)
-2.55 -2.32 -1.97 -1.54 -0.85 -0.6 -0.41
EPS (Diluted)
-2.55 -2.32 -1.97 -1.54 -0.85 -0.6 -0.41
EBITDA
-86.63M -73.41M -58.44M -50.35M -26.82M -17.8M -11.42M
EBIT
-86.48M -75.8M -61.38M -50.35M -26.82M -17.8M -11.42M
Depreciation & Amortization
-963.03K -2.3M -3.59M -7.84M -4.03M -2.7M -1.49M